| Entry |
|
|---|
| Name |
Fluocinonide (JP17/USP/INN);
Lidex (TN);
Vanos (TN)
|
|---|
| Product |
FLUOCINONIDE (Alvogen), FLUOCINONIDE (Alvogen), FLUOCINONIDE (County Line Pharmaceuticals), FLUOCINONIDE (County Line Pharmaceuticals), FLUOCINONIDE (Lake Erie Medical DBA Quality Care Products LLC), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (Preferred Pharmaceuticals), FLUOCINONIDE (Taro Pharmaceuticals U.S.A.), VANOS (Valeant Pharmaceuticals North America LLC), FLUOCINONIDE CREAM (EMULSIFIED BASE) (Alvogen), FLUOCINONIDE GEL (Alvogen) |
|---|
| Generic |
FLUOCINONIDE (A-S Medication Solutions), FLUOCINONIDE (Actavis Pharma), FLUOCINONIDE (Aidarex Pharmaceuticals LLC), FLUOCINONIDE (Amneal Pharmaceuticals LLC), FLUOCINONIDE CREAM (Amneal Pharmaceuticals LLC), FLUOCINONIDE (Cadila Healthcare Limited), FLUOCINONIDE (Central Texas Community Health Centers), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINONIDE (G&W Laboratories), FLUOCINONIDE (G&W Laboratories), FLUOCINONIDE (Glasshouse Pharmaceuticals Limited Canada), FLUOCINONIDE (Glenmark Pharmaceuticals), FLUOCINONIDE (H.J. Harkins Company), FLUOCINONIDE (IPG PHARMACEUTICALS), FLUOCINONIDE (IPG PHARMACEUTICALS), FLUOCINONIDE (IPG PHARMACEUTICALS), FLUOCINONIDE (Impax Generics), FLUOCINONIDE (Lake Erie Medical DBA Quality Care Products LLC), FLUOCINONIDE (Macleods Pharmaceuticals Limited), FLUOCINONIDE (Mayne Pharma), FLUOCINONIDE (MedVantx), FLUOCINONIDE (NORTHSTAR RX LLC), FLUOCINONIDE (Novel Laboratories), FLUOCINONIDE (Novel Laboratories), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (NuCare Pharmaceuticals), FLUOCINONIDE (Oceanside Pharmaceuticals), FLUOCINONIDE (Perrigo New York), FLUOCINONIDE (Pharmaceutica North America), FLUOCINONIDE (Preferred Pharmaceuticals), FLUOCINONIDE (Preferred Pharmaceuticals), FLUOCINONIDE (Preferred Pharmaceuticals), FLUOCINONIDE (Preferred Pharmaceuticals), FLUOCINONIDE (Proficient Rx LP), FLUOCINONIDE (Proficient Rx LP), FLUOCINONIDE (REMEDYREPACK), FLUOCINONIDE (RPK Pharmaceuticals), FLUOCINONIDE (Rebel Distributors Corp), FLUOCINONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINONIDE (Teligent Pharma), FLUOCINONIDE (Teligent Pharma), FLUOCINONIDE (Teligent Pharma), FLUOCINONIDE (Teva Pharmaceuticals USA), FLUOCINONIDE (Zydus Pharmaceuticals (USA)) |
|---|
| Formula |
C26H32F2O7
|
|---|
| Exact mass |
494.2116
|
|---|
| Mol weight |
494.5249
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 2646 |
|
|---|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07225 | Glucocorticoid and mineralocorticoid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA Corticosteroids
C05AA11 Fluocinonide
D00325 Fluocinonide (JP17/USP/INN) <JP/US>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC08 Fluocinonide
D00325 Fluocinonide (JP17/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Fluocinonide
D00325 Fluocinonide (JP17/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
2646 Adrenocorticotropic hormones
D00325 Fluocinonide (JP17/USP/INN)
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D00325 Fluocinonide (JP17/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00325 Fluocinonide
Topical steroids potency [br08317.html]
Classification in the USA
D00325
Classification in Japan
D00325
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 35
1 C2x C 18.6900 -28.5600
2 C5x C 18.6900 -29.8900
3 C2x C 19.8800 -30.5900
4 C2y C 21.0700 -29.8900
5 C1z C 21.0700 -28.5600
6 C2x C 19.8800 -27.8600
7 C1y C 22.2600 -30.5900
8 C1x C 23.4500 -29.8900
9 C1y C 23.4500 -28.5600
10 C1z C 22.2600 -27.8600
11 C1y C 24.5700 -27.8600
12 C1z C 24.5700 -26.5300
13 C1x C 23.4500 -25.8300
14 C1y C 22.2600 -26.5300
15 C1x C 26.9500 -27.8600
16 C1y C 26.9500 -26.5300
17 C1z C 25.7600 -25.8300
18 O5x O 17.5700 -30.5900
19 C1a C 21.0700 -27.1600
20 X F 22.2600 -29.1900
21 O1a O 21.0700 -25.8300
22 C1a C 24.5700 -25.1300
23 C5a C 25.7600 -24.2200
24 O2x O 27.1600 -24.9200
25 O5a O 26.9500 -23.5200
26 C1b C 24.5700 -23.5200
27 O7a O 23.4500 -24.2200
28 O2x O 28.3500 -26.5300
29 C1z C 28.5600 -24.9200
30 C1a C 29.9600 -24.9200
31 C1a C 28.5600 -23.5200
32 X F 22.2600 -31.9900
33 C7a C 22.2138 -23.5629
34 C1a C 20.9972 -24.3229
35 O6a O 22.1654 -22.1902
BOND 39
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 2 18 2
22 5 19 1 #Up
23 10 20 1 #Down
24 14 21 1 #Up
25 12 22 1 #Up
26 17 23 1 #Up
27 17 24 1 #Down
28 23 25 2
29 23 26 1
30 26 27 1
31 16 28 1 #Down
32 24 29 1
33 29 28 1
34 29 30 1
35 29 31 1
36 7 32 1 #Down
37 27 33 1
38 33 34 1
39 33 35 2
|
|---|
|
